Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-24-021869)

Filing Details

Accession Number:: 0001415889-24-021869
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-21 18:38:07
Reporting Period:: 2024-08-19

Accepted Time:: 2024-08-21 18:38:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1662774	Quince Therapeutics Inc.	QNCX	Biological Products, (No Disgnostic Substances) (2836)	901024039

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1929422	Brendan Hannah	C/O Quince Therapeutics, Inc. 611 Gateway Blvd, Suite 273 South San Francisco CA 94080	Chief Business Officer And Coo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-08-19	2,155	$0.58	259,771	No	4	P	Direct
Common Stock	Acquisiton	2024-08-20	2,500	$0.61	262,271	No	4	P	Direct
Common Stock	Acquisiton	2024-08-20	3,424	$0.60	265,695	No	4	P	Direct
Common Stock	Acquisiton	2024-08-21	2,280	$0.61	267,975	No	4	P	Direct
Common Stock	Acquisiton	2024-08-21	5,000	$0.62	272,975	No	4	P	Direct
Common Stock	Acquisiton	2024-08-21	23,565	$0.63	296,540	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct